期刊文献+

全心衰竭与胆碱酯酶相关性研究 被引量:10

Research of Correlativity between Heart Failure and Cholinesterase
下载PDF
导出
摘要 目的研究慢性充血性全心衰竭患者血清胆碱酯酶水平与心力衰竭严重程度及心力衰竭症状加重持续时间的相关性。方法测定212例患者的血清胆碱酯酶水平,分析血清胆碱酯酶水平与慢性充血性全心衰竭患者心功能严重程度及心力衰竭症状加重持续时间的相关性。结果血清胆碱酯酶水平随着心功能的下降而逐渐下降(r=-0.849,P<0.01),血清胆碱酯酶水平随着心力衰竭症状加重持续时间的延长而逐渐下降(r=-0.863,P<0.01)。结论血清胆碱酯酶水平可作为评价慢性充血性全心衰竭患者心功能及病程的较好参考指标。 Objective To study the correlativity between serum cholinesterase levels of patients with chronic congestive heart failure and the severity of heart failure,the duration of heart failure aggravation.Methods To determine the serum cholinesterase level of 212 patients,to analyze serum cholinesterase levels,the severity of heart function in patients with chronic congestive heart failure,the duration of heart failure symptoms.Results The serum cholinesterase level declined gradually with the drop of cardiac function(r=-0.849,P0.01),and also declined with the duration increasing of heart failure(r=-0.863,P0.01).Conclusion The serum cholinesterase levels can be a better reference index as a evaluation of chronic congestive heart failure and disease course.
出处 《医学综述》 2010年第17期2683-2684,共2页 Medical Recapitulate
关键词 慢性充血性 全心衰竭 肝功能 胆碱酯酶 病程 Chronic congestive Heart failure Liver function Cholinesterase Course of disease
  • 相关文献

参考文献12

二级参考文献44

共引文献78

同被引文献86

  • 1刘玉峰.还原型谷胱甘肽联合葡醛内酯治疗急性有机磷农药中毒后肝损伤38例[J].现代中西医结合杂志,2007,16(26). 被引量:2
  • 2刘秀娟,刘伯仁,张谦,龙永锦.多器官功能障碍综合征血清白蛋白及胆碱酯酶水平的意义和预后的关系[J].陕西医学杂志,2008,37(7):835-836. 被引量:11
  • 3王超,张淑文,阴赬宏,王红,王宝恩.近年来北京地区多器官功能障碍综合征流行病学调查[J].中华创伤杂志,2004,20(12):730-733. 被引量:33
  • 4巴立,张茂,干建新,江观玉.严重多发伤患者早期血清胆碱酯酶活性检测的意义[J].中华创伤杂志,2006,22(8):624-625. 被引量:10
  • 5Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail,2008,10: 933-989.
  • 6Allen LA, Felker GM, Pocock S, et al.Liver function abnormali- ties and outcome in patients with chronic heart failure:data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail, 2009, 11 : 170-177.
  • 7Ambrosy AP, Vaduganathan M, Huffman MD, et al. Clinical course and predictive value of liver function tests in patients hos- pitalized for worsening heart failure with reduced ejection frac- tion: an analysis of the EVEREST trial. Eur J Heart Fail, 2012,14 : 302-311.
  • 8Mattes CE, Lynch T J, Singh A, et al. Therapeutic use of butyrylcho- lineaterase for cocaine intoxication. Toxicology and Applied Pharmacology, 1997, 145(2): 372-380.
  • 9Frolich L. The cholinergic pathologyin Alzheimer' s disease discrepancies between clinical experience andpathophysiological findings. Neural Transm, 2002,109(7-8):1003-1013.
  • 10施新萍,楼利剑,娄域峰.肺部疾病引发全身炎症反应综合征的老年患者死亡因素分析.中华危重症医学杂志,2011,4(1):26-30.

引证文献10

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部